• About Us
  • Our Editorial Policy
  • Business Directory
  • Advertise with Us
  • Our Advertisers
  • Contact Us
Australia India News
India News Australia
  • Home
  • Current Issue
    Past Issue
  • India News
  • Politics
  • Business
  • World
    World This Week
  • Community News
  • What's On
  • Others
    Yoga in Australia News COVID-19 Community News Naari IPL News Health Travel Entertainment
  • Migrants Expo
  • National Events
  • Please wait..
Science

Bangladesh: Three more people die due to dengue, 2025 death toll rises to 135

  • BY India News Newsdesk
  • September 8, 2025
  • 0 COMMENTS

Dhaka, Sep 7 (IANS) Three more people have died due to dengue in the past 24 hours till Sunday morning, increasing the number of deaths from the mosquito-borne disease in Bangladesh to 135 in 2025.

The recent deaths have been reported in Dhaka South City Corporation (DSCC), Chattogram Division (outside city corporation areas) and Mymensingh Division, according to the Directorate General of Health Services (DGHS), the United News of Bangladesh reported.

During the period, 580 new patients were admitted to hospitals with viral fever, raising the total number of cases to 34,411 in 2025.

According to the DGHS data, new cases were reported in 128 in Barishal Division (Out of CC), 94 in Chattogram Division (Out of CC), 85 in Dhaka North City Corporation, 85 in Dhaka Division (Out of CC), 80 in Dhaka South City Corporation, 55 in Rajshahi (Out of CC), 32 in Khulna Division (Out of CC), 17 in Mymensingh (Out of CC), three in Rangpur division and one in Sylhet division (Out of CC).

As of now, 1571 people were undergoing treatment in hospitals in Bangladesh. As many as 575 people died due to dengue in Bangladesh in 2024. A total of 101,214 dengue cases and 100,040 recoveries were reported in Bangladesh in the same year, according to the DGHS data.

As many as 39 people died due to dengue while 10,496 new cases were reported in the month of August, according to DGHS, Bangladesh-based daily New Age reported. Bangladesh reported 41 deaths due to dengue in July, while the total number of patients was 10,684.

Dengue is a viral infection that is spread from mosquitoes to people. It is more common in tropical and subtropical climates than in temperate ones, according to the World Health Organisation (WHO).

The majority of people who get dengue do not have symptoms. For those who do, the most common symptoms are high fever, headache, body aches, nausea and rash. The majority of the patients get better in one or two weeks; however, some develop severe dengue and need care in a hospital. Dengue can be fatal in severe cases.

–IANS

akl/vd

Post navigation

Exporters to meet RBI chief for easier loan terms amid US tariff hike
Ahead of Vice-Prez election, BJP holds key meeting with PM Modi in attendance

Related Post

New positive for Hantavirus confirmed among quarantined Spaniards
May 26, 2026
SC asks states, UTs to implement menstrual hygiene directions in schools by Aug 15
May 26, 2026
Awami League slams Yunus govt over massive measles outbreak in Bangladesh
May 26, 2026
Bangladesh measles outbreak death toll rises to 545 as 17 more children die
May 26, 2026

Our Current Issue

Australia IA – May 16-31, 2026

Alluring India 2026

Alluring India 2026

Our Advertisers

  • Battery Rebate australia
  • Bess Australia Solar Panels

Follow Us

  • facebook
  • facebook
  • facebook
  • facebook
INDIA NEWS on YouTube in Australia, bring to our readers and subscribers national and international news, editorials, expert columns, community activities and interviews of political leaders, celebrities, business professionals, academics and sport personalities among others.
  • facebook
  • facebook
  • facebook
  • facebook

Category

  • Accident
  • Adani Australia
  • Advertorial
  • Arts & Culture
  • Ashes 2022
  • Australia

Recent News

  • India’s real estate demand outpaces institutional investments:...
  • ‘Sabka Saath, Sabka Vikas’: NDA leaders praise...

Subscribe Newsletter

Get the latest creative news from india news

  • Privacy Policy
  • Disclaimer